Sources | Names Used |
---|---|
CTRPv2 | selumetinib:vorinostat (8:1 mol/mol) |
PharmacoGx | selumetinib:vorinostat (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HCFC2 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | TAGLN | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | CYP3A5 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | GREM2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | KIR3DL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CAP2 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-06 |
mRNA | FAM180A | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |